AUTOMA+ 2025 to take place in Vösendorf, Austria from November 24-25: Our Bureau, Mumbai Monday, August 11, 2025, 09:00 Hrs [IST] The Pharmaceutical Automation and Digitalisation ...

Exports of Ayush and herbal products for the first three months of FY26 has reported a marginal growth of 0.58%, as compared ...

Pharma & CROs turn to hybrid cloud infrastructure to safeguard sensitive patient information: Nandita Vijayasimha, Bengaluru Monday, August 11, 2025, 08:00 Hrs [IST] Pharma compan ...

No further extension of deadline for online submission of WHO-GMP COPP applications: DCGI: Gireesh Babu, New Delhi Monday, August 11, 2025, 08:00 Hrs [IST] After extending the tim ...

Kerala IPA to launch one-year programmes to upskill pharmacy professionals: Peethaambaran Kunnathoor, Chennai Monday, August 11, 2025, 08:00 Hrs [IST] The Kerala branch of the Ind ...

Urgent need for standardization in dental education and clinical practices: Dr Ashok Dhoble: Shardul Nautiyal, Mumbai Monday, August 11, 2025, 08:00 Hrs [IST] Dr Ashok Dhoble, sec ...

Cosmo Pharmaceuticals N.V., a global leader in AI-driven healthcare and specialty pharmaceuticals, announced the renewal of its multi-year manufacturing and supply agreement with Takeda, to produce ...

Genmab A/S, an international biotechnology company with a core purpose of guiding its unstoppable team to strive toward improving the lives of patients with innovative and differentiated antibody ...

Dogwood Therapeutics doses first fifty patients in ongoing Halneuron phase 2b CINP clinical trials: Atlanta Saturday, August 9, 2025, 18:00 Hrs [IST] Dogwood Therapeutics Inc, a d ...

Kedrion Biopharma receives US FDA orphan drug designation for plasma-derived treatment for congenital aceruloplasminemia: Forte Lee, New Jersey Saturday, August 9, 2025, 17:00 Hrs ...

ProteinQure gets US FDA and Health Canada regulatory clearances to begin phase I trial of PQ203 in US and Canada: Toronto Saturday, August 9, 2025, 16:00 Hrs [IST] ProteinQure, a ...

GSK plc announces that, in connection with the mRNA patent settlement reached between CureVac and BioNTech on 7th August, 2025, the company will receive an upfront settlement of $370 million. GSK will ...